Name: Acumen Pharmaceuticals, Inc. (ABOS) Balance Sheet
Creator: FinSpry

Acumen Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Acumen Pharmaceuticals, Inc. (ABOS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	35.63	66.89	130.10	122.16	43.78
Short-Term Investments	135.93	176.64	47.50	72.08	0.00
Cash & Short-Term Investments	171.56	243.52	177.61	194.24	43.78
Accounts Receivable	0.40	0.23	0.11	0.10	0.11
Inventory	0.16	0.10	0.20	0.08	0.09
Other Current Assets	5.33	1.96	1.11	1.51	0.01
Total Current Assets	178.31	246.62	180.33	198.66	44.43
Non-Current Assets
Property, Plant & Equipment (Net)	0.34	0.50	0.27	0.04	0.00
Long-Term Investments	59.97	62.55	15.84	31.62	0.00
Intangible Assets	0.08	0.17	0.00	0.00	0.00
Other Non-Current Assets	0.30	0.24	0.15	0.01	0.00
Total Non-Current Assets	60.69	63.51	16.26	31.67	0.00
Total Assets	238.99	310.13	196.59	230.33	44.43
Current Liabilities
Accounts Payable	5.65	1.38	1.64	1.09	0.53
Short-Term Debt	0.13	0.00	0.00	0.00	0.00
Accrued Liabilities	17.39	6.82	5.94	3.86	0.33
Other Current Liabilities	0.23	0.21	0.13	0.20	5.50
Total Current Liabilities	27.61	12.97	7.81	5.15	6.37
Non-Current Liabilities
Long-Term Debt	28.45	27.34	0.00	0.00	0.00
Other Non-Current Liabilities	0.00	4.67	0.00	0.15	0.00
Total Non-Current Liabilities	29.57	30.18	0.24	0.15	0.00
Total Liabilities	57.18	43.15	7.81	5.15	6.37
Stockholders' Equity
Common Stock	0.01	0.01	0.00	0.00	0.00
Retained Earnings	-325.13	-222.80	-170.43	-127.57	-26.97
Accumulated Other Comprehensive Income	-0.05	0.31	-0.75	-0.23	0.00
Additional Paid-in Capital	506.99	489.45	359.95	352.98	0.00
Shares Outstanding	60.09	57.91	41.03	40.47	0.00
Total Stockholders' Equity	181.82	266.97	188.78	225.18	38.06
Total Liabilities & Equity	238.99	310.13	196.59	230.33	0.00